How to Read a 10-K: The Sections Every Investor Should Understand

The 10-K is the most honest document a public company produces all year. It's the annual report every U.S. domestic public company files with the SEC — audited, legally binding, and written in the knowledge that lying in it is a federal crime. (Foreign companies listed here via ADRs file a close cousin, the Form 20-F.) Which is exactly why the marketing gloss you see everywhere else tends to go quiet inside it.

So learning how to read a 10-K is one of the highest-leverage skills in investing. Not because you'll read all 200 pages — you won't, and you don't need to — but because knowing which sections carry the signal lets you check a company's story against its own sworn filing in an afternoon.

This guide walks the 10-K section by section: what each part is for, what "good" and "concerning" tend to look like, and the warning signs that hide in the parts most people skip. Keep the Valarn glossary open in another tab if a term is unfamiliar.

The 10-K in one map#

A 10-K is long, but it's not random. It follows a fixed structure the SEC dictates, so once you know the layout you can navigate any company's filing the same way. Here's the map, with the parts that actually reward your attention:

Read in that order and you're doing real 10-K analysis — moving from the business, through the risks, into the numbers, and down to the fine print where the numbers get explained. If you'd rather see the finished picture first, a complete sample research report shows what all of this looks like once it's pulled together.

Item 1 — Business: how the money is actually made#

Start here, always. Item 1 is the company describing itself in plain, legally accountable language — no ad copy, no investor-day sizzle reel. You want to finish this section able to explain, in two sentences, who the customer is, what they pay for, and how often.

The most valuable thing in Item 1 is the segment breakdown. Big companies report revenue by business line and often by geography, and that split usually tells a different story than the headline number. A company that looks like a diversified tech giant might turn out to earn 80% of its profit from one product. That's not necessarily bad — but you can't judge concentration you don't know about.

• Look for: a revenue model you can name, disclosed segment and geographic splits, and a customer base that isn't dangerously concentrated.
• Be wary of: a business described only in buzzwords, or a filing that reveals one product, one customer, or one region carries the whole company.

When you want to orient yourself on a specific ticker before opening the filing, a company research page is a fast way in. And because Item 1 is really the foundation for everything else, it maps directly onto the first steps of our 12-step stock research checklist.

Item 1A — Risk Factors: read what changed, not the whole list#

Risk Factors is where companies list everything that could hurt them. The instinct is to skim it, because much of it reads like defensive boilerplate — "competition is intense," "we may not sustain growth," "cybersecurity incidents could harm us." True, but useless on their own.

The trick to reading this section is comparison, not consumption. Pull last year's 10-K next to this year's and look for what's new. When a company adds a risk factor, removes one, or moves one higher up the list, that's a deliberate legal decision — someone decided the risk landscape changed enough to say so in writing. A newly added risk about a key supplier, a specific regulation, or customer concentration is worth more than the forty generic paragraphs around it.

• Look for: risks that name specific, company-level dangers, and any risk that appeared or grew more prominent since last year.
• Be wary of: a risk section that suddenly gets much longer, or a new "going concern" style warning about the company's ability to keep operating (more on that below).

Item 3 — Legal Proceedings: the lawsuits that matter#

Companies only have to disclose legal matters that are material — meaning big enough to affect the business or the numbers. So the mere presence of litigation isn't alarming; every large company is sued constantly. What you're scanning for is the case large enough to reshape earnings: a major patent fight, a regulatory investigation, a class action with real dollar exposure.

Cross-reference anything meaningful here against the footnotes in Item 8, where the potential financial impact of legal contingencies is usually quantified or explained. A lawsuit mentioned in Item 3 and then reserved against in the financials is a very different thing from one the company insists is immaterial.

Item 7 — MD&A: management explains itself#

Management's Discussion and Analysis is the most human section of the 10-K — it's leadership narrating their own results in prose. This is where the raw numbers from the financials get a "why." Revenue rose 12%; MD&A tells you whether that came from selling more, raising prices, an acquisition, or a currency swing. Those are four very different stories behind one identical number.

Read MD&A for two things. First, the explanations: does management attribute results to durable drivers or to one-off luck? Second, the emphasis: what they choose to highlight versus what they mention once and move past. When a company leads with an adjusted metric it invented and buries the GAAP result, note it. When margins compressed and the explanation is a single vague sentence, note that too.

This section is close cousin to a quarterly earnings report, and the skill of reading management's framing transfers directly. Our companion guide, how to analyze an earnings report, breaks down that read in detail — the same instincts apply to the annual MD&A.

• Look for: specific, candid explanations of what drove the numbers, and consistency between what management emphasizes and what the financials show.
• Be wary of: results attributed entirely to "macro conditions," heavy reliance on adjusted figures, and language that gets noticeably more promotional as the underlying trends weaken.

Item 8 — The financial statements: where earnings meet reality#

This is the audited core: three statements that, read together, tell you whether the business is genuinely healthy. Don't just read the current year's figures — pull the multi-year comparisons the filing provides and look at the shape of the trend.

The income statement#

Top to bottom: revenue, the costs of producing it, operating expenses, and finally net income. Track the margins across years — gross, operating, and net — because the trend matters more than any single level. Expanding margins usually signal pricing power or improving efficiency; quietly eroding margins can mean rising competition or a company buying growth it can't sustain.

The balance sheet and debt#

The balance sheet tells you whether the company can survive a bad year. Check the debt load relative to earnings and equity, whether there's enough cash to cover near-term obligations, and — critically — when the debt comes due. A maturity wall arriving in a year when refinancing is expensive can turn an ordinary downturn into a crisis. Debt itself isn't the enemy; debt that's large relative to shaky cash flows is.

The cash flow statement#

Earnings are an opinion; cash is a fact. Go to operating cash flow and free cash flow (operating cash flow minus capital spending) and ask the one question that catches a surprising number of problems: does reported profit actually turn into cash? Over time, free cash flow and net income should move roughly together. A company that keeps posting profits but never generates cash is telling you something — aggressive revenue recognition, ballooning inventory, or customers who aren't paying.

• Look for: margins holding or improving, manageable leverage with a clean maturity schedule, and profit that converts into real cash.
• Be wary of: profits that never become cash, free cash flow that only looks healthy because the company stopped investing in itself, or a debt maturity crowded into one difficult year.

The footnotes: where the real disclosures live#

Almost everyone stops at the statements. The footnotes are where the numbers get explained — and where the most important disclosures often hide in dense, deliberately dull prose. Three areas repay the effort every time.

Stock-based compensation (SBC). How much of employee pay is issued in shares rather than cash? SBC doesn't hit cash flow, so it's easy to ignore, but it dilutes you — every share issued shrinks your slice of the company. A firm handing out 3% of its shares in comp each year is quietly transferring ownership away from existing holders. Check the share-count trend: is it flat, or creeping up year after year?

Accounting policy changes. When a company changes how it recognizes revenue or values inventory, growth can appear or vanish without the underlying business changing at all. The footnotes disclose these shifts. A change in policy that conveniently flatters the current year deserves a hard second look.

Related-party transactions. Deals between the company and its own executives, directors, or entities they control. Most are benign, but this is where genuine governance problems surface — a company leasing property from its CEO, or doing meaningful business with a director's private firm. Small, clean, well-disclosed items are routine; large or vague ones are a flag.

How to spot what changed from last year#

The single most powerful SEC filing analysis technique costs nothing: read two years side by side. A 10-K in isolation is a snapshot; two in sequence is a trend. Open this year's filing and last year's and compare the same sections:

• Risk Factors — what was added, removed, or promoted?
• Segment revenue — is a once-fast segment now slowing, or a small one becoming the whole story?
• Accounting policies — did anything material change in how the numbers are built?
• The auditor — did the company switch audit firms, and does the report explain why?
• Share count — how fast is it growing, and is buyback activity keeping pace with dilution?

Changes are where the information density is highest. Companies write these documents carefully; when they alter language they've used for years, it's rarely an accident.

Warning signs investors frequently overlook#

Once you can navigate a 10-K, a handful of patterns separate a clean filing from one that warrants extra caution. None is a verdict on its own — but each is a thread worth pulling.

• Recurring "one-time" charges. Restructuring, impairments, and "non-recurring" items that show up year after year aren't one-time; they're operating costs the company would rather you excluded. If the same "special" charge appears in three consecutive 10-Ks, it's just a cost.
• A widening gap between GAAP and adjusted numbers. Adjusted (non-GAAP) earnings can be legitimate, but watch the gap. When a company reports, say, $500M in "adjusted" earnings against $200M in GAAP net income, the $300M of add-backs is where the story lives. A gap that grows every year is management steadily redefining what counts as profit.
• Dilution through stock-based comp. As above — rising share counts quietly reduce your ownership even as the company touts "record" adjusted results that conveniently ignore the cost of those shares.
• "Going concern" language. If the auditors or management raise "substantial doubt about the ability to continue as a going concern," that is the most serious warning a filing can carry, stated in plain legal terms. Never skim past it.
• Related-party items that keep growing. One small disclosed transaction is normal; an expanding web of deals with insiders is a governance question you're entitled to ask.

Insider behavior around a filing is another useful piece of context — executives disclose their own buying and selling separately in Form 4s, and reading those as other people's dated actions (never as a signal aimed at you) adds color to what the 10-K says. Our guide on what insider buying and selling means covers how to weigh it honestly.

The shortcut: let a research desk read it with you#

Done properly, this is hours of work per company — pulling two years of filings, comparing risk sections line by line, reconciling GAAP to adjusted, tracing legal exposure into the footnotes. That's exactly the work most people skip, which is how "I read the 10-K" so often means "I read the summary someone posted."

Valarn was built to do this legwork as an educational research tool. Instead of one AI handing you a confident paragraph, it convenes up to about 25 specialist analysts — covering business quality, financial statements, earnings and guidance, insiders, sentiment, catalysts, and a dedicated risk committee — each grounded in primary filings, then stages a structured bull-versus-bear debate before synthesizing a single research view (Bullish, Cautious Bullish, Neutral, Cautious, or Bearish — never a buy/sell order). Every factual claim is traceable to a filing or licensed source with an as-of date, a quality-assurance gate runs before the report reaches you, and each report carries two separate 0–100 scores — a confidence score for how complete and reliable the underlying data is, and an agreement score for how much the analysts converged. Instead of a single price target, you get a Scenario Range and a Reference Price.

The point isn't to read the filing for you so you can stop thinking — it's to surface the recurring "one-time" charge or the widening GAAP gap you'd have to know exactly where to look to catch. If you want to judge whether an AI report clears that bar, we wrote ten checks for trusting AI stock analysis precisely so you can grade one yourself.

The bottom line#

A 10-K isn't there to tell you what to do — it's there to let you check what a company says against what it's legally sworn to be true. Learning how to read a 10-K means knowing where the signal lives: the segment splits in Item 1, the changes in the risk factors, the "why" in MD&A, the cash reality in the statements, and the fine print in the footnotes where dilution and related-party deals hide. Read two years side by side, watch for the warning signs, and you'll be forming a view from the primary source instead of someone's summary of it.

That's the whole point — not a tidy answer handed to you, but a document you can actually interrogate. Want to see it come together on a real company? Skim a full sample report, or run your own free research report and watch the filing get read section by section.

Valarn is an educational research tool, not investment advice. It does not tell you to buy, sell, or hold anything, and nothing here is a recommendation or a promise of results. Always do your own research and consider consulting a licensed financial professional.